|
1
|
Balbo S, Upadhyaya P, Villalta PW, Qian X
and Kassie F: DNA adducts in aldehyde dehydrogenase-positive lung
stem cells of A/J mice treated with the tobacco specific lung
carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Chem Res Toxicol. Mar 12–2013.(Epub ahead of print).
|
|
2
|
Akopyan G and Bonavida B: Understanding
tobacco smoke carcinogen NNK and lung tumorigenesis (Review). Int J
Oncol. 29:745–752. 2006.PubMed/NCBI
|
|
3
|
Chen RJ, Chang LW, Lin P and Wang YJ:
Epigenetic effects and molecular mechanisms of tumorigenesis
induced by cigarette smoke: an overview. J Oncol.
2011:6549312011.PubMed/NCBI
|
|
4
|
Belinsky SA, Devereux TR, Foley JF,
Maronpot RR and Anderson MW: Role of the alveolar type II cell in
the development and progression of pulmonary tumors induced by
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse.
Cancer Res. 52:3164–3173. 1992.PubMed/NCBI
|
|
5
|
Imaida K, Yokohira M and Kuno T: Detection
of carcinogenic and modifying potentials by test compounds using a
mouse lung carcinogenesis bioassay (Review). J Toxicol Pathol.
20:117–123. 2007. View Article : Google Scholar
|
|
6
|
Takeuchi H, Saoo K, Matsuda Y, et al:
8-Methoxypsoralen, a potent human CYP2A6 inhibitor, inhibits lung
adenocarcinoma development induced by
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice.
Mol Med Rep. 2:585–588. 2009.
|
|
7
|
Takeuchi H, Saoo K, Matsuda Y, et al: Dose
dependent inhibitory effects of dietary 8-methoxypsoralen on
NNK-induced lung tumorigenesis in female A/J mice. Cancer Lett.
234:232–238. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takeuchi H, Saoo K, Yokohira M, et al:
Pretreatment with 8-methoxypsoralen, a potent human CYP2A6
inhibitor, strongly inhibits lung tumorigenesis induced by
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice.
Cancer Res. 63:7581–7583. 2003.
|
|
9
|
Yokohira M, Takeuchi H, Saoo K, et al:
Establishment of a bioassay model for lung cancer chemoprevention
initiated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
in female A/J mice. Exp Toxicol Pathol. 60:469–473. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kuno T, Yokohira M, Matsuda Y, et al: Lack
of modifying potential of 8-methoxypsoralen in the promotion or
progression stages of lung carcinogenesis in A/J female mice. Oncol
Rep. 20:767–772. 2008.PubMed/NCBI
|
|
11
|
Matsuda Y, Saoo K, Hosokawa K, et al:
Post-initiation chemopreventive effects of dietary bovine
lactoferrin on
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung
tumorigenesis in female A/J mice. Cancer Lett. 246:41–46. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamakawa K, Kuno T, Hashimoto N, et al:
Molecular analysis of carcinogen-induced rodent lung tumors:
Involvement of microRNA expression and Kras or Egfr mutations. Mol
Med Rep. 3:141–147. 2010.PubMed/NCBI
|
|
13
|
Yokohira M, Hashimoto N, Yamakawa K, Saoo
K, Kuno T and Imaida K: Lack of promoting effects from physical
pulmonary collapse in a female A/J mouse lung tumor initiated with
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) with
remarkable mesothelial cell reactions in the thoracic cavity by the
polymer. Exp Toxicol Pathol. 63:181–185. 2011. View Article : Google Scholar
|
|
14
|
Yokohira M, Hashimoto N, Yamakawa K, et
al: Lack of modifying effects of intratracheal instillation of
quartz or dextran sulfate sodium (DSS) in drinking water on lung
tumor development initiated with
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female A/J
mice. J Toxicol Pathol. 22:179–185. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyazaki M, Yamazaki H, Takeuchi H, et al:
Mechanisms of chemopreventive effects of 8-methoxypsoralen against
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung
adenomas. Carcinogenesis. 26:1947–1955. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Igarashi M, Watanabe M, Yoshida M, et al:
Enhancement of lung carcinogenesis initiated with
4-(N-hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone by
Ogg1 gene deficiency in female, but not male, mice. J
Toxicol Sci. 34:163–174. 2009.
|
|
17
|
Morita T: A statistical study of lung
cancer in the annual of pathological autopsy cases in Japan, from
1958 to 1997, with reference to time trends of lung cancer in the
world. Jpn J Cancer Res. 93:15–23. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sobue T, Ajiki W, Tsukuma H, Oshima A,
Hanai A and Fujimoto I: Trends of lung cancer incidence by
histologic type: a population-based study in Osaka, Japan. Jpn J
Cancer Res. 90:6–15. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zang EA and Wynder EL: Differences in lung
cancer risk between men and women: examination of the evidence. J
Natl Cancer Inst. 88:183–192. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Belani CP, Marts S, Schiller J and
Socinski MA: Women and lung cancer: epidemiology, tumor biology,
and emerging trends in clinical research. Lung Cancer. 55:15–23.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nishio M, Ohyanagi F, Horiike A, et al:
Gefitinib treatment affects androgen levels in non-small-cell lung
cancer patients. Br J Cancer. 92:1877–1880. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mohr U: International Classification of
Rodent Tumors: The Mouse. 1st edition. Springer-Verlag; Berlin:
2001, View Article : Google Scholar
|
|
23
|
de Kretser DM: The Testis. Reproduction in
Mammals: Hormonal Control of Reproduction. Austin CR and Short RV:
3. 2nd edition. Cambridge University Press; Cambridge: pp. 76–90.
1984
|
|
24
|
Baird DT: The Ovary. Reproduction in
Mammals: Hormonal Control of Reproduction. Austin CR and Short RV:
3. 2nd edition. Cambridge University Press; Cambridge: pp. 91–114.
1984, View Article : Google Scholar
|
|
25
|
Pelletier G, Luu-The V, Li S and Labrie F:
Localization of type 5 17β-hydroxysteroid dehydrogenase mRNA in
mouse tissues as studied by in situ hybridization. Cell Tissue Res.
320:393–398. 2005.
|
|
26
|
Matsuura S and Suzuki K: Morphological
changes in the submandibular glands and in the X zone of the
adrenal gland following ovariectomy in mice. Cell Tissue Res.
246:549–556. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kamei Y, Suzuki M, Miyazaki H, et al:
Ovariectomy in mice decreases lipid metabolism-related gene
expression in adipose tissue and skeletal muscle with increased
body fat. J Nutr Sci Vitaminol. 51:110–117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu J, Wang X, Chiba H, et al: Combined
intervention of soy isoflavone and moderate exercise prevents body
fat elevation and bone loss in ovariectomized mice. Metabolism.
53:942–948. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamaguchi M, Katoh S, Morimoto C, et al:
The hormonal responses of lipoprotein lipase activity and lipolysis
in adipose tissue differ depending on the stage of the estrous
cycle in female rats. Int J Obes Relat Metab Disord. 26:610–617.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Duffel MW, Graham JM and Ziegler DM:
Changes in dimethylaniline N-oxidase activity of mouse liver and
kidney induced by steroid sex hormones. Mol Pharmacol. 19:134–139.
1981.PubMed/NCBI
|
|
31
|
Kamataki T, Fujita KI, Nakayama K,
Yamazaki Y, Miyamoto M and Ariyoshi N: Role of human cytochrome
P450 (CYP) in the metabolic activation of nitrosamine derivatives:
application of genetically engineered Salmonella expressing
human CYP. Drug Metab Rev. 34:667–676. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wiener D, Doerge DR, Fang JL, Upadhyaya P
and Lazarus P: Characterization of N-glucuronidation of the
lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol
(NNAL) in human liver: importance of UDP-glucuronosyltransferase
1A4. Drug Metab Dispos. 32:72–79. 2004.
|
|
33
|
Benowitz NL, Lessov-Schlaggar CN, Swan GE
and Jacob P III: Female sex and oral contraceptive use accelerate
nicotine metabolism. Clinl Pharmacol Ther. 79:480–488. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miners JO, Grgurinovich N, Whitehead AG,
Robson RA and Birkett DJ: Influence of gender and oral
contraceptive steroids on the metabolism of salicytic acid and
acetylsalicylic acid. Br J Clin Pharmacol. 22:135–142. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mitchell MC, Hanew T, Meredith CG and
Schenker S: Effects of oral contraceptive steroids on acetaminophen
metabolism and elimination. Clin Pharmacol Ther. 34:48–53. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Stoehr GP, Kroboth PD, Juhl RP, Wender DB,
Phillips JP and Smith RB: Effect of oral contraceptives on
triazolam, temazepam, alprazolam, and lorazepam kinetics. Clin
Pharmacol Ther. 36:683–690. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Balogh A, Klinger G, Henschel L, Börner A,
Vollanth R and Kuhnz W: Influence of ethinylestradiol-containing
combination oral contraceptives with gestodene or levonorgestrel on
caffeine elimination. Eur J Clin Pharmacol. 48:161–166. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Laine K, Tybring G and Bertilsson L: No
sex-related differences but significant inhibition by oral
contraceptives of CYP2C19 activity as measured by the probe drugs
mephenytoin and omeprazole in healthy Swedish white subjects. Clin
Pharmacol Ther. 68:151–159. 2000. View Article : Google Scholar
|
|
39
|
Slayter KL, Ludwig EA, Lew KH, Middleton E
Jr, Ferry JJ and Jusko WJ: Oral contraceptive effects on
methylprednisolone pharmacokinetics and pharmacodynamics. Clin
Pharmacol Ther. 59:312–321. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mikkonen L, Pihlajamaa P, Sahu B, Zhang FP
and Jänne OA: Androgen receptor and androgen-dependent gene
expression in lung. Mol Cell Endocrinol. 317:14–24. 2010.
View Article : Google Scholar : PubMed/NCBI
|
